5,863 followers
New Research: Off-label use of Baricitinib improves moderate and severe atopic dermatitis in China through inhibiting MAPK and PI3K/Akt/mTOR pathway via targeting JAK-STAT signaling of CD4+ cells https://t.co/xnNMGCEB81 #pharmacology